In a nonprecedential decision, the Court of Appeals for the Federal Circuit looked at the issue of whether there is an Article III case or controversy between a patentee drug company and a generic drug company in the context of the Hatch-Waxman Act. Merck v. Apotex (07-1362). Merck had sued Apotex for patent infringement when […]